<?xml version="1.0" encoding="UTF-8"?>
<p id="Par27">Sofosbuvir, a nucleotide analog that brought revolutionary changes in the treatment of the hepatitis C virus, has been found to decrease genotype 3 HEV replication in vitro [
 <xref ref-type="bibr" rid="CR56">56</xref>]. Valk et al. reported a case of chronic hepatitis E in an immunocompromised patient where sofosbuvir showed antiviral activity [
 <xref ref-type="bibr" rid="CR57">57</xref>â€¢]. Wezel et al. observed that sofosbuvir showed antiviral activity in chronic HEV-infected three solid organ transplant patients but failed to achieve sustained virological response [
 <xref ref-type="bibr" rid="CR58">58</xref>].
</p>
